Protective effects of 1α,25-(OH)2D3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture

被引:192
作者
Ibi, M
Sawada, H
Nakanishi, M
Kume, T
Katsuki, H
Kaneko, S
Shimohama, S
Akaike, A [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Sakyo Ku, Kyoto 6068501, Japan
关键词
1; alpha; 25-(OH)(2)D-3; neuroprotection glutamate; dopaminergic neuron; mesencephalon;
D O I
10.1016/S0028-3908(01)00009-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study was undertaken to determine whether 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25-(OH)(2)D-3], an active metabolite of vitamin D, protects dopaminergic neurons against the neurotoxic effects of glutamate and dopaminergic toxins using rat mesecephalic culture. Brief glutamate exposure elicited cytotoxicity in both dopaminergic and non-dopaminergic neurons. Pretreatment, but not co-administration, of 1 alpha ,25-(OH)(2)D-3 protected both types of neurons against the cytotoxicity of glutamate in a concentration- and time-dependent manner. The neuroprotective effect of 1 alpha ,25-(OH)(2)D-3 was inhibited by the protein synthesis inhibitor, cycloheximide. To investigate the mechanisms of these neuroprotective effects, we examined the effects of 1 alpha .25-(OH)(2)D-3 on neurotoxicity induced by calcium ionophore and reactive oxygen species (ROS). Pretreatment with 1 alpha ,25-(OH)(2)D-3 protected both types of neurons against the cytotoxicity induced by A23187 in a concentration-dependent manner. Furthermore, 24-h pretreatment with 1 alpha .25-(OH)(2)D-3 concentration-dependently protected both types of neurons from ROS-induced cytotoxicity. A 24-h incubation with 1 alpha ,25-(OH)(2)D-3 inhibited the increase in intracellular ROS level following H2O2 exposure. A 24-h exposure to 1-methyl-4-phenylpyridium ion (MPP+) or 6-hydroxydopamine (6-OHDA) exerted selective neurotoxicity on dopaminergic neurons, and these neurotoxic effects were ameliorated by 1 alpha -25-(OH)(2)D-3. These results suggest that 1 alpha ,25-(OH)(2)D-3 provides protection of dopaminergic neurons against cytotoxicity induced by glutamate and dopaminergic toxins by facilitating cellular functions that reduce oxidative stress. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:761 / 771
页数:11
相关论文
共 33 条
[1]  
Baudet C, 1996, J NEUROSCI RES, V46, P540, DOI 10.1002/(SICI)1097-4547(19961201)46:5<540::AID-JNR3>3.0.CO
[2]  
2-J
[3]  
Bayne K, 1996, PHYSIOLOGIST, V39, P208
[4]  
Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870
[5]   Reversible parkinsonism, hypophosphoremia, and hypocalcemia under vitamin D therapy [J].
Derex, L ;
Trouillas, P .
MOVEMENT DISORDERS, 1997, 12 (04) :612-613
[6]   Protective effect of thioredoxin upon NO-mediated cell injury in THP1 monocytic human cells [J].
Ferret, PJ ;
Soum, E ;
Negre, O ;
Wollman, EE ;
Fradelizi, D .
BIOCHEMICAL JOURNAL, 2000, 346 (pt 3) :759-765
[7]   Expression of vitamin D receptor (VDR) in HL-60 cells is differentially regulated during the process of differentiation induced by phorbol ester, retinoic acid or interferon-γ [J].
Folgueira, MAAK ;
Federico, MHH ;
Katayama, MLH ;
Silva, MRP ;
Brentani, MM .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 66 (04) :193-201
[8]   1,25-dihydroxyvitamin D3 regulates the synthesis of γ-glutamyl transpeptidase and glutathione levels in rat primary astrocytes [J].
Garcion, E ;
Sindji, L ;
Leblondel, G ;
Brachet, P ;
Darcy, F .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) :859-866
[9]   The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed [J].
Haussler, MR ;
Whitfield, GK ;
Haussler, CA ;
Hsieh, JC ;
Thompson, PD ;
Selznick, SH ;
Dominguez, CE ;
Jurutka, PW .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (03) :325-349
[10]   Depletion of intracellular glutathione increases susceptibility to nitric oxide in mesencephalic dopaminergic neurons [J].
Ibi, M ;
Sawada, H ;
Kume, T ;
Katsuki, H ;
Kaneko, S ;
Shimohama, S ;
Akaike, A .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (04) :1696-1703